Option Care Health, Inc.
Business
Option Care Health, Inc. is the largest independent provider of home and alternate site infusion services, operating 196 locations across 43 states. The company delivers infusion therapy including anti-infectives, nutrition support, immunoglobulin therapy, chronic inflammatory disorder treatments, and neurological disorder therapies through a network of full-service pharmacies and ambulatory infusion suites. Option Care Health serves patients, managed care organizations, hospitals, physicians, and pharmaceutical manufacturers, generating revenue primarily through third-party payer contracts and government healthcare programs.
Summary from 10-K filed 2026-02-24
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| NET REVENUE | 5,650 | 4,998 | 4,302 | 3,945 | 3,439 | |
| COST OF REVENUE | 4,562 | 3,985 | 3,321 | 3,078 | 2,659 | |
| GROSS PROFIT | 1,088 | 1,013 | 981 | 867 | 780 | |
| Selling, general and administrative expenses | 682 | 630 | 607 | 566 | 526 | |
| Depreciation and amortization expense | 68 | 61 | 59 | 61 | 63 | |
| Total operating expenses | 750 | 691 | 667 | 627 | 589 | |
| OPERATING INCOME | 338 | 322 | 315 | 240 | 191 | |
| Interest expense, net | −55 | −49 | −51 | −54 | — | |
| Equity in earnings of joint ventures | 7 | 6 | 6 | 5 | 6 | |
| Other, net | −8 | 5 | 90 | 14 | −13 | |
| Total other (expense) income | −55 | −38 | 44 | −34 | — | |
| INCOME BEFORE INCOME TAXES | 283 | 284 | 359 | 206 | 116 | |
| INCOME TAX EXPENSE | 75 | 72 | 92 | 55 | −23 | |
| NET INCOME | 208 | 212 | 267 | 151 | 140 | |
| Change in unrealized (loss) gain on cash flow hedges, net of income tax benefit (expense) of $2,272, $1,284, and $2,158, respectively | −7 | −4 | −6 | 22 | — | |
| OTHER COMPREHENSIVE (LOSS) INCOME | −7 | −4 | −6 | 22 | 11 | |
| NET COMPREHENSIVE INCOME | 201 | 208 | 261 | 172 | 151 | |
| Earnings per share, basic (in dollars per share) | 1.28 | 1.23 | 1.49 | 0.83 | 0.78 | |
| Earnings per share, diluted (in dollars per share) | 1.27 | 1.23 | 1.48 | 0.83 | 0.77 | |
| Weighted average common shares outstanding, basic (in shares) | 162 | 172 | 179 | 181 | 180 | |
| Weighted average common shares outstanding, diluted (in shares) | 163 | 173 | 180 | 182 | 181 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 233 | 413 | 344 | 294 | 119 | |
| Accounts receivable, net | 474 | 410 | 378 | 378 | 338 | |
| Inventories | 471 | 388 | 274 | 224 | 183 | |
| Prepaid expenses and other current assets | 88 | 112 | 99 | 98 | 69 | |
| Total current assets | 1,265 | 1,323 | 1,094 | 994 | 710 | |
| Property and equipment, net | 139 | 127 | 121 | 108 | 112 | |
| Operating lease right-of-use asset | 91 | 87 | 84 | 72 | 75 | |
| Intangible assets, net | 22 | 17 | 20 | 22 | 21 | |
| Referral sources, net | 287 | 284 | 315 | 342 | 345 | |
| Goodwill | 1,607 | 1,540 | 1,540 | 1,533 | 1,478 | |
| Other noncurrent assets | 44 | 44 | 42 | 40 | 24 | |
| Total noncurrent assets | 2,191 | 2,099 | 2,123 | 2,119 | 2,081 | |
| TOTAL ASSETS | 3,456 | 3,422 | 3,217 | 3,113 | 2,791 | |
| Accounts payable | 640 | 611 | 427 | 379 | 279 | |
| Accrued compensation and employee benefits | 70 | 63 | 93 | 77 | 84 | |
| Accrued expenses and other current liabilities | 88 | 78 | 75 | 84 | 72 | |
| Current portion of operating lease liability | 24 | 22 | 18 | 19 | 19 | |
| Current portion of long-term debt | 7 | 7 | 6 | 6 | 6 | |
| Total current liabilities | 829 | 780 | 618 | 565 | 460 | |
| Long-term debt, net of discount, deferred financing costs and current portion | 1,154 | 1,105 | 1,057 | 1,058 | 1,060 | |
| Operating lease liability, net of current portion | 89 | 85 | 85 | 71 | 74 | |
| Deferred income taxes | 56 | 48 | 35 | 22 | 0 | |
| Other noncurrent liabilities | 1 | 366,000 | 0 | 10 | 21 | |
| Total noncurrent liabilities | 1,300 | 1,237 | 1,177 | 1,161 | 1,155 | |
| Total liabilities | 2,129 | 2,018 | 1,795 | 1,727 | 1,615 | |
| Preferred stock; $0.0001 par value; 12,500,000 shares authorized, no shares outstanding as of December 31, 2025 and 2024 | 0 | 0 | 0 | 0 | 0 | |
| Common stock; $0.0001 par value: 250,000,000 shares authorized, 184,522,423 shares issued and 156,857,801 shares outstanding as of December 31, 2025; 183,846,725 shares issued and 166,261,112 shares outstanding as of December 31, 2024 | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 | |
| Treasury stock; 27,664,622 and 17,585,613 shares outstanding, at cost, as of December 31, 2025 and 2024, respectively | −818 | −508 | −255 | −2 | −2 | |
| Paid-in capital | 1,264 | 1,231 | 1,204 | 1,177 | 1,139 | |
| Retained earnings | 877 | 669 | 458 | 190 | 40 | |
| Accumulated other comprehensive income (loss) | 4 | 11 | 15 | 21 | −451,000 | |
| Total stockholders equity | 1,326 | 1,404 | 1,422 | 1,386 | 1,176 | |
| TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | 3,456 | 3,422 | 3,217 | 3,113 | 2,791 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization expense | 71 | 63 | 62 | 65 | 69 | |
| Non-cash operating lease costs | 25 | 23 | 19 | 20 | 15 | |
| Deferred income taxes, net | 8 | 13 | 13 | 49 | −30 | |
| Loss on extinguishment of debt | 5 | 377,000 | 0 | 0 | 13 | |
| Amortization of deferred financing costs | 4 | 5 | 4 | 4 | 5 | |
| Equity in earnings of joint ventures | −7 | −6 | −6 | −5 | −6 | |
| Stock-based incentive compensation expense | 40 | 36 | 30 | 17 | 10 | |
| Distribution from equity method investments | 4 | 2 | 4 | 6 | 3 | |
| Other adjustments | 1 | −5 | −1 | 0 | 844,000 | |
| Accounts receivable, net | −55 | −32 | 224,000 | −37 | −4 | |
| Inventories | −81 | −114 | −51 | −41 | −23 | |
| Prepaid expenses and other current assets | 18 | −16 | −6 | −17 | 1 | |
| Accounts payable | 20 | 183 | 48 | 99 | −10 | |
| Accrued compensation and employee benefits | 6 | −29 | 16 | −8 | 24 | |
| Accrued expenses and other current liabilities | 10 | 6 | −2 | 11 | 18 | |
| Operating lease liabilities | −24 | −22 | −18 | −21 | −18 | |
| Other noncurrent assets and liabilities | 7 | 3 | −8 | −15 | 700,000 | |
| Net cash provided by operating activities | 258 | 323 | 371 | 268 | 209 | |
| Acquisition of property and equipment | −41 | −36 | −42 | −35 | −26 | |
| Proceeds from sale of assets | 0 | 0 | 4 | 15 | 0 | |
| Business acquisitions, net of cash acquired | −117 | 0 | −12 | −87 | −86 | |
| Other investing activities | −3 | −864,000 | −6 | 0 | 0 | |
| Net cash used in investing activities | −161 | −36 | −57 | −108 | −112 | |
| Stock-based compensation tax withholdings | −11 | −12 | −3 | — | −32,000 | |
| Purchase of company stock and related excise taxes | −310 | −253 | −250 | 0 | 0 | |
| Proceeds from issuance of debt | 229 | 50 | 0 | 0 | 855 | |
| Repayments of debt principal | −5 | −6 | −6 | −6 | −9 | |
| Retirement of debt obligations | −180 | 0 | 0 | — | — | |
| Deferred financing costs | −3 | −77,000 | 0 | 0 | −10 | |
| Other financing activities | 2 | 3 | −6 | 0 | 0 | |
| Net cash used in financing activities | −277 | −218 | −265 | 15 | −77 | |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | −180 | 69 | 50 | 175 | 20 | |
| Cash paid for interest | 65 | 72 | 70 | 50 | 61 | |
| Income Taxes Paid, Net | 67 | 65 | 75 | 13 | 6 | |
| Cash paid for operating leases | 31 | 29 | 27 | 25 | 26 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Option Care Health, Inc.'s CIK number?
Option Care Health, Inc.'s SEC CIK number is 0001014739 (1014739). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Option Care Health, Inc.'s SEC filings?
All of Option Care Health, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Option Care Health, Inc. last report earnings?
Option Care Health, Inc. (OPCH) most recently filed an earnings 8-K with the SEC on Apr 30, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001104659-26-052099). This is Option Care Health, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Option Care Health, Inc.'s most recent earnings 8-K?
Option Care Health, Inc.'s latest earnings 8-K (Item 2.02) was filed Apr 30, 2026 under accession 0001104659-26-052099. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Option Care Health, Inc.'s latest earnings 8-K →
Look up any company's CIK number →